Wrinkle in Allergan's Forecast: Need a Shot of Botox?
Read the full article: http://www.ockhamresearch.com
Allergan Inc., the maker of Botox and many other products was down more than3% today after forecast a tough consumer spending environment in the U.S market. While that may be true, much of that concern is already priced into the stock. We think Allergan is priced attractively for a long term value play.
- Login or register to post comments
- Email this page
